0001209191-20-020124.txt : 20200318
0001209191-20-020124.hdr.sgml : 20200318
20200318201400
ACCESSION NUMBER: 0001209191-20-020124
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200316
FILED AS OF DATE: 20200318
DATE AS OF CHANGE: 20200318
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Krishnan Suma
CENTRAL INDEX KEY: 0001298711
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38210
FILM NUMBER: 20726154
MAIL ADDRESS:
STREET 1: 1861 PRATT DRIVE
STREET 2: SUITE 1090
CITY: BLACKSBURG
STATE: VA
ZIP: 24060
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Krystal Biotech, Inc.
CENTRAL INDEX KEY: 0001711279
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 821080209
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2100 WHARTON STREET
STREET 2: SUITE 701
CITY: PITTSBURGH
STATE: PA
ZIP: 15203
BUSINESS PHONE: (412) 586-5830
MAIL ADDRESS:
STREET 1: 2100 WHARTON STREET
STREET 2: SUITE 701
CITY: PITTSBURGH
STATE: PA
ZIP: 15203
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-03-16
0
0001711279
Krystal Biotech, Inc.
KRYS
0001298711
Krishnan Suma
C/O KRYSTAL BIOTECH, INC.
2100 WHARTON STREET, SUITE 701
PITTSBURGH
PA
15203
1
1
1
0
Chief Operating Officer
Common Stock
2020-03-16
4
S
0
2559
40.1384
D
1948903
D
Common Stock
2020-03-17
4
S
0
10780
40.4851
D
1938123
D
Common Stock
2020-03-17
4
S
0
1396
41.2658
D
1936727
D
Common Stock
2020-03-17
4
S
0
4
42.03
D
1936723
D
Common Stock
2020-03-18
4
S
0
659
40.2018
D
1936064
D
Common Stock
112162
I
By trust
Common Stock
1936462
I
By spouse
The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person following discussions with the Compensation Committee and the Board of Directors.
This transaction was executed in multiple trades ranging from $40.00 to $40.46. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
This transaction was executed in multiple trades ranging from $40.00 to $40.99. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
This transaction was executed in multiple trades ranging from $41.00 to $41.86. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
This transaction was executed in multiple trades ranging from $40.00 to $40.45. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
Directly beneficially owned by the Krishnan Family Trust. The reporting person and her spouse are each joint beneficial owners of the trust with joint voting and investment control.
Directly beneficially owned by Krish S. Krishnan, the spouse of the reporting person.
/s/ Suma Krishnan
2020-03-18